Entrada Therapeutics, Inc. (TRDA) Dividend Yield, History & Forecast
Entrada Therapeutics, Inc. (TRDA) is a Biotechnology company in the Healthcare sector listed on the NASDAQ Global Market. market capitalization is approximately $503M.
Frequently Asked Questions about Entrada Therapeutics, Inc. (TRDA)
Is Entrada Therapeutics, Inc. a Dividend Aristocrat?▾
Dividend Aristocrat status requires an S&P 500 listing and 25 or more consecutive years of dividend increases. See our curated Dividend Aristocrats list for the full roster.
What sector is Entrada Therapeutics, Inc. in?▾
Entrada Therapeutics, Inc. (TRDA) operates in the Healthcare sector, specifically the Biotechnology industry.